We're #hiring a new Non-Clinical Study Manager in Greater Boston. Apply today or share this post with your network.
Trace Neuroscience
Biotechnology Research
South San Francisco, California 1,605 followers
Breakthrough Science for People Suffering from Neurodegenerative Diseases
About us
Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells.
- Website
-
www.traceneuro.com
External link for Trace Neuroscience
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- South San Francisco, California
- Type
- Privately Held
- Founded
- 2024
Locations
-
Primary
750 Gateway Blvd
Suite 200
South San Francisco, California 94080, US
Employees at Trace Neuroscience
Updates
-
Check it out! Our founder and CEO Eric Green recently joined #TheGeneticsPodcast to chat about his journey to Trace - from his time in cardiology to honing in on #genetic modifiers to discover new therapies for #ALS. Listen below. ⬇️
Episode 166 of #TheGeneticsPodcast is live 🚀 This week Patrick is joined by Eric Green, Founder and CEO of Trace Neuroscience, Co-Founder and Chief Scientific Officer at Maze Therapeutics, and Adjunct Clinical Assistant Professor at Stanford University School of Medicine. Listen in to hear them discuss: 🔍The role of highly focused #biotechs in harnessing genetic insights to create precision therapies for rare disease subtypes 🧬 How Trace’s work on the UNC13A gene is bringing new hope to #ALS patients 🫀 Eric’s journey from a career in #cardiology to the world of entrepreneurship and biotechnology 🏗️ Building Maze Therapeutics and Eric’s focus on genetic modifiers to discover new drugs And much more. Listen by following the link below👇 or simply search “The Genetics Podcast” on your go-to podcast platform. 🎧 https://pod.fo/e/293697 📽️ https://lnkd.in/dWrBkzcz Please consider rating and reviewing us on your chosen podcast listening platform! #SanoGenetics #Genomics #Genetics #RareDisease #Neurology
-
We're #hiring a new Senior Director, Regulatory Affairs in Boston, MA or South San Francisco, CA. Apply today or share this post with your network.
-
Did you know approximately 30,000 people in the U.S. are living with amyotrophic lateral sclerosis, and 1 in 400 people around the world will be diagnosed with #ALS during their lifetime? Introducing Trace Neuroscience, a company built on scientific breakthroughs with a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases, starting with ALS. Our initial focus is developing a novel genomic therapy that restores UNC13A protein to re-establish healthy communication between nerves and muscle cells, to improve muscle function and quality of life, slow disease progression and extend survival. Learn more: https://lnkd.in/eAQJW7Qc